Global Clinical Trial Supplies Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	175 Pages	TechNavio	May, 2024	INF18930048

Best Price Guarantee
Price	from $2,500
Length	175 Pages
Publisher	TechNavio
Published Date	May, 2024
SKU	INF18930048

Global Clinical Trial Supplies Market 2024-2028

The clinical trial supplies market is forecasted to grow by USD 1312.9 mn during 2023-2028, accelerating at a CAGR of 8.65% during the forecast period. The report on the clinical trial supplies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of biopharmaceutical industry, government initiatives on clinical research, and regulation of clinical trials in regional markets.

Technavio's clinical trial supplies market is segmented as below:

By End-user

Pharmaceutical industry
Biologics industry
Medical device industry

By Type

Phase III
Phase II
Phase IV and BE/BA studies
Phase I

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing demand for cros as one of the prime reasons driving the clinical trial supplies market growth during the next few years. Also, increase in studies focusing on pharmaceutical industry and rising demand for e-clinical trials will lead to sizable demand in the market.

The report on the clinical trial supplies market covers the following areas:

Clinical trial supplies market sizing
Clinical trial supplies market forecast
Clinical trial supplies market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trial supplies market vendors that include Ancillare LP, Avantor Inc., Bionical Emas Group, Bushu Pharmaceuticals Ltd., Catalent Inc., Clinical Services International Ltd., Clinigen Group Plc, Deutsche Bahn AG, Emsere B.V, GNH India Pharmaceuticals Ltd., International Bonded Couriers Inc., Nuvisan GmbH, Obvio Health USA Inc., Parexel International Corp., PCI Pharma Services, PHOENIX Pharmahandel GmbH and Co KG, Piramal Enterprises Ltd., Precision Medicine Group LLC, Thermo Fisher Scientific Inc., and Vertical Pharma Resources Ltd.. Also, the clinical trial supplies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Clinical Trial Supplies Market 2018 - 2022; Historic Market Size - Data Table on Global Clinical Trial Supplies Market 2018 - 2022 ($ million); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Pharmaceutical industry - Market size and forecast 2023-2028; Chart on Pharmaceutical industry - Market size and forecast 2023-2028 ($ million); Data Table on Pharmaceutical industry - Market size and forecast 2023-2028 ($ million); Chart on Pharmaceutical industry - Year-over-year growth 2023-2028 (%); Data Table on Pharmaceutical industry - Year-over-year growth 2023-2028 (%); 6.4 Biologics industry - Market size and forecast 2023-2028; Chart on Biologics industry - Market size and forecast 2023-2028 ($ million); Data Table on Biologics industry - Market size and forecast 2023-2028 ($ million); Chart on Biologics industry - Year-over-year growth 2023-2028 (%); Data Table on Biologics industry - Year-over-year growth 2023-2028 (%); 6.5 Medical device industry - Market size and forecast 2023-2028; Chart on Medical device industry - Market size and forecast 2023-2028 ($ million); Data Table on Medical device industry - Market size and forecast 2023-2028 ($ million); Chart on Medical device industry - Year-over-year growth 2023-2028 (%); Data Table on Medical device industry - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Phase III - Market size and forecast 2023-2028; Chart on Phase III - Market size and forecast 2023-2028 ($ million); Data Table on Phase III - Market size and forecast 2023-2028 ($ million); Chart on Phase III - Year-over-year growth 2023-2028 (%); Data Table on Phase III - Year-over-year growth 2023-2028 (%); 7.4 Phase II - Market size and forecast 2023-2028; Chart on Phase II - Market size and forecast 2023-2028 ($ million); Data Table on Phase II - Market size and forecast 2023-2028 ($ million); Chart on Phase II - Year-over-year growth 2023-2028 (%); Data Table on Phase II - Year-over-year growth 2023-2028 (%); 7.5 Phase IV and BE/BA studies - Market size and forecast 2023-2028; Chart on Phase IV and BE/BA studies - Market size and forecast 2023-2028 ($ million); Data Table on Phase IV and BE/BA studies - Market size and forecast 2023-2028 ($ million); Chart on Phase IV and BE/BA studies - Year-over-year growth 2023-2028 (%); Data Table on Phase IV and BE/BA studies - Year-over-year growth 2023-2028 (%); 7.6 Phase I - Market size and forecast 2023-2028; Chart on Phase I - Market size and forecast 2023-2028 ($ million); Data Table on Phase I - Market size and forecast 2023-2028 ($ million); Chart on Phase I - Year-over-year growth 2023-2028 (%); Data Table on Phase I - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape2023-2028 (%); Data Table on Market share By Geographical Landscape2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity by geography; Market opportunity By Geographical Landscape($ million); Data Tables on Market opportunity By Geographical Landscape($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Ancillare LP; Ancillare LP - Overview; Ancillare LP - Product / Service; Ancillare LP - Key offerings; 12.4 Avantor Inc.; Avantor Inc. - Overview; Avantor Inc. - Business segments; Avantor Inc. - Key news; Avantor Inc. - Key offerings; Avantor Inc. - Segment focus; 12.5 Bushu Pharmaceuticals Ltd.; Bushu Pharmaceuticals Ltd. - Overview; Bushu Pharmaceuticals Ltd. - Product / Service; Bushu Pharmaceuticals Ltd. - Key offerings; 12.6 Clinigen Group Plc; Clinigen Group Plc - Overview; Clinigen Group Plc - Product / Service; Clinigen Group Plc - Key offerings; 12.7 Deutsche Bahn AG; Deutsche Bahn AG - Overview; Deutsche Bahn AG - Product / Service; Deutsche Bahn AG - Key offerings; 12.8 Emsere B.V; Emsere B.V - Overview; Emsere B.V - Product / Service; Emsere B.V - Key offerings; 12.9 International Bonded Couriers Inc.; International Bonded Couriers Inc. - Overview; International Bonded Couriers Inc. - Product / Service; International Bonded Couriers Inc. - Key offerings; 12.10 Nuvisan GmbH; Nuvisan GmbH - Overview; Nuvisan GmbH - Product / Service; Nuvisan GmbH - Key offerings; 12.11 Obvio Health USA Inc.; Obvio Health USA Inc. - Overview; Obvio Health USA Inc. - Product / Service; Obvio Health USA Inc. - Key offerings; 12.12 Parexel International Corp.; Parexel International Corp. - Overview; Parexel International Corp. - Product / Service; Parexel International Corp. - Key offerings; 12.13 PCI Pharma Services; PCI Pharma Services - Overview; PCI Pharma Services - Product / Service; PCI Pharma Services - Key offerings; 12.14 PHOENIX Pharmahandel GmbH and Co KG; PHOENIX Pharmahandel GmbH and Co KG - Overview; PHOENIX Pharmahandel GmbH and Co KG - Product / Service; PHOENIX Pharmahandel GmbH and Co KG - Key news; PHOENIX Pharmahandel GmbH and Co KG - Key offerings; 12.15 Piramal Enterprises Ltd.; Piramal Enterprises Ltd. - Overview; Piramal Enterprises Ltd. - Product / Service; Piramal Enterprises Ltd. - Key offerings; 12.16 Precision Medicine Group LLC; Precision Medicine Group LLC - Overview; Precision Medicine Group LLC - Product / Service; Precision Medicine Group LLC - Key offerings; 12.17 Vertical Pharma Resources Ltd.; Vertical Pharma Resources Ltd. - Overview; Vertical Pharma Resources Ltd. - Product / Service; Vertical Pharma Resources Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Clinical Trial Supplies Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Pharmaceutical industry - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Pharmaceutical industry - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Pharmaceutical industry - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Pharmaceutical industry - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Biologics industry - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Biologics industry - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Biologics industry - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Biologics industry - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Medical device industry - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Medical device industry - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Medical device industry - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Medical device industry - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by End-user ($ million); Exhibits49: Data Table on Market opportunity by End-user ($ million); Exhibits50: Chart on Type - Market share 2023-2028 (%); Exhibits51: Data Table on Type - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Type; Exhibits53: Data Table on Comparison by Type; Exhibits54: Chart on Phase III - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Phase III - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Phase III - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Phase III - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Phase II - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Phase II - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Phase II - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Phase II - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Phase IV and BE/BA studies - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Phase IV and BE/BA studies - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Phase IV and BE/BA studies - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Phase IV and BE/BA studies - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Phase I - Market size and forecast 2023-2028 ($ million); Exhibits67: Data Table on Phase I - Market size and forecast 2023-2028 ($ million); Exhibits68: Chart on Phase I - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Phase I - Year-over-year growth 2023-2028 (%); Exhibits70: Market opportunity by Type ($ million); Exhibits71: Data Table on Market opportunity by Type ($ million); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape2023-2028 (%); Exhibits74: Data Table on Market share By Geographical Landscape2023-2028 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape($ million); Exhibits114: Data Tables on Market opportunity By Geographical Landscape($ million); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Matrix on companies position and classification; Exhibits121: Ancillare LP - Overview; Exhibits122: Ancillare LP - Product / Service; Exhibits123: Ancillare LP - Key offerings; Exhibits124: Avantor Inc. - Overview; Exhibits125: Avantor Inc. - Business segments; Exhibits126: Avantor Inc. - Key news; Exhibits127: Avantor Inc. - Key offerings; Exhibits128: Avantor Inc. - Segment focus; Exhibits129: Bushu Pharmaceuticals Ltd. - Overview; Exhibits130: Bushu Pharmaceuticals Ltd. - Product / Service; Exhibits131: Bushu Pharmaceuticals Ltd. - Key offerings; Exhibits132: Clinigen Group Plc - Overview; Exhibits133: Clinigen Group Plc - Product / Service; Exhibits134: Clinigen Group Plc - Key offerings; Exhibits135: Deutsche Bahn AG - Overview; Exhibits136: Deutsche Bahn AG - Product / Service; Exhibits137: Deutsche Bahn AG - Key offerings; Exhibits138: Emsere B.V - Overview; Exhibits139: Emsere B.V - Product / Service; Exhibits140: Emsere B.V - Key offerings; Exhibits141: International Bonded Couriers Inc. - Overview; Exhibits142: International Bonded Couriers Inc. - Product / Service; Exhibits143: International Bonded Couriers Inc. - Key offerings; Exhibits144: Nuvisan GmbH - Overview; Exhibits145: Nuvisan GmbH - Product / Service; Exhibits146: Nuvisan GmbH - Key offerings; Exhibits147: Obvio Health USA Inc. - Overview; Exhibits148: Obvio Health USA Inc. - Product / Service; Exhibits149: Obvio Health USA Inc. - Key offerings; Exhibits150: Parexel International Corp. - Overview; Exhibits151: Parexel International Corp. - Product / Service; Exhibits152: Parexel International Corp. - Key offerings; Exhibits153: PCI Pharma Services - Overview; Exhibits154: PCI Pharma Services - Product / Service; Exhibits155: PCI Pharma Services - Key offerings; Exhibits156: PHOENIX Pharmahandel GmbH and Co KG - Overview; Exhibits157: PHOENIX Pharmahandel GmbH and Co KG - Product / Service; Exhibits158: PHOENIX Pharmahandel GmbH and Co KG - Key news; Exhibits159: PHOENIX Pharmahandel GmbH and Co KG - Key offerings; Exhibits160: Piramal Enterprises Ltd. - Overview; Exhibits161: Piramal Enterprises Ltd. - Product / Service; Exhibits162: Piramal Enterprises Ltd. - Key offerings; Exhibits163: Precision Medicine Group LLC - Overview; Exhibits164: Precision Medicine Group LLC - Product / Service; Exhibits165: Precision Medicine Group LLC - Key offerings; Exhibits166: Vertical Pharma Resources Ltd. - Overview; Exhibits167: Vertical Pharma Resources Ltd. - Product / Service; Exhibits168: Vertical Pharma Resources Ltd. - Key offerings; Exhibits169: Inclusions checklist; Exhibits170: Exclusions checklist; Exhibits171: Currency conversion rates for US$; Exhibits172: Research methodology; Exhibits173: Information sources; Exhibits174: Data validation; Exhibits175: Validation techniques employed for market sizing; Exhibits176: Data synthesis; Exhibits177: 360 degree market analysis; Exhibits178: List of abbreviations